Validation of the French version of the Munich Dysphagia Test-Parkinson’s disease (MDT-PD) in a multilingual population of the Luxembourg Parkinson’s Study (HELP-PD)
Objective: To provide the psychometric validation of the French MDT-PD in the Luxembourgish multilingual population. Background: The MDT-PD, developed and validated in German [1], is…Apathy in Parkinson’s disease is associated with REM sleep behavior disorder
Objective: To assess apathy and its relationship with cognitive functions in PD patients with and without Rapid Eye Movement Sleep Behavior Disorder (RBD). Background: Apathy…Gut microbiota geography in Parkinson’s disease in the world
Objective: The 16 rRNA analysis and the shotgun metagenome analysis in our cohort were compared with 5 previous reports by others. Background: In PD patients,…The subthalamic stimulation inhibit bladder contraction by modulating local field potential and monoamine in the medial prefrontal cortex
Objective: We aimed to clarify the changes in neuronal activity (local field potential and levels of monoamine) of mPFC induced by STN-DBS with relation to…Levodopa-induced dyskinesia in Parkinson’s disease: Sleep matters
Objective: To investigate the relationship between slow wave activity (SWA) of non-rapid eye movement (NREM) sleep, which underlies adjustment of cortical excitability, and levodopa-induced dyskinesias…Experimental rotenone model
Objective: To evaluat rotene model of parkinsonian syndrome in rats. Background: Rotenone is of highly lipophilic substances that can freely enter hematoencephalic barrier through and…T lymphocytes in Parkinson’s disease pathogenesis and therapy: A systematic review
Objective: A systematic literature review was conducted to synthesize the current state of knowledge on the role of T lymphocytes in Parkinson’s disease (PD) pathology…Interaction of TDP-43 with IAPP in pancreatic beta cells of patients with sinucleinopathies
Objective: We have investigated whether deposits of phosphorylated TDP-43 might be present in pancreatic tissue of patients with synucleinopathies. Background: The TAR DNA binding protein…A post-mortem and in vivo study of neuroinflammation and Toll like-receptors in Parkinson’s disease
Objective: To investigate inflammatory change and Toll-like receptor (TLR) expression in human post-mortem Parkinson’s disease (PD) brains and to test the efficacy of TLR-blocking agents…Natural occurring antibodies reduce aggregation of α-synuclein
Objective: We tested naturally occurring antibodies (nAbs) against α-synuclein both in vitro as well as in HEK293T cells to determine binding, cell viability and capacity…
- « Previous Page
- 1
- …
- 113
- 114
- 115
- 116
- 117
- …
- 177
- Next Page »